Founded in 2020, HemostOD is a biotech company based in Lausanne, Switzerland.
We are a preclinical stage company developing a therapeutic platform based on engineered platelets to provide an alternative to blood donor platelet transfusion.
Platelets On Demand
for the patients
Platelets are small blood cells whose function is to stop bleeding.
We create a new source of platelets, manufactured on demand, to relieve blood banks and hospitals. An efficient alternative to blood donor platelets.
Universal and safe, our platelets provide a reliable access to platelet transfusions for all.
Beyond transfusions, standardized manufacturable platelets also open the way to new treatment opportunities.
Today, patients with low platelet count (a condition known as thrombocytopenia) only rely on blood donations. These life-saving transfusions are facing recurrent shortage issues and present a risk of life-threatening complications for multi-transfused patients.
are transfused every year
of platelet transfusions target
patients in onco-hematology
$ 6.7 Billion
represents the global
transfusion market in 2021
A Unique & Scalable
Platelet Production Technology
Inspired by platelet biology to save lives.